Caffeine reduce hepatic lipid accumulation through regulation of lipogenesis and ER stress in zebraf

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:czh1078
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:The aims of this study are to induce fatty liver in zebrafish larvae by overfeeding approach and to examine the effects of caffeine on hepatic lipid accumulation in overfeeding zebrafish larva.Methods:100 zebrafish larvae from a single cluster at 5dpf were allocated to a series of different amount of feeding groups:20mg/d,30mg/d,60mg/d,80mg/d,120mg/d and 180mg/d and fed for 10,15,and 20 days.By observing the morphological and pathological changes in zebrafish,the growth and the hepatic steatosis in different quantity and duration of feeding group were evaluated.For caffeine treatment,larvae were overfed with 1 %,2.5 %,5 %and 8 %caffeine for 20 days,the effect and mechanism of caffeine on hepatic steatosis in zebrafish were explored via evaluating histological changes in liver and examinating the body weight,lipid contents,and associated genes expression with qRT-PCR.
其他文献
Background:Objectives:Fuzheng Huayu(FZHY) capsule,a Chinese medicine,is widely administrated to treat hepatic fibrosis and cirrhosis in the clinic in China for twenty years.This abstract is about to s
会议
Background:The zinc finger protein A20(also known as TNFAIP3) is a cytoplasmic protein and mediates the regulation of ubiquitin-dependent signaling in inflammation and immunity.Complex immune networks
会议
Background:Incidence of NAFLD(nonalcoholic fatty liver disease) is increasing as a cause of chronic liver disease.Also,obesity and diabetes are risk factors for the development of hepatocellular carci
会议
Background:It is of great importance to early and accurately predict the prognosis of patients with acute-onchronic hepatitis B liver failure(ACHBLF) for optimum management.The promoter methylation of
会议
Background:Hepatitis B virus core-related antigens(HBcrAg) are comprised of hepatitis B core antigen(HBcAg),hepatitis E antigen(HBeAg) and a 22 kDa precore protein(P22cr).HBcrAg concentrations were we
会议
Background:To compare the efficacy and safety of 52-week sequential therapy with telbivudine and other nucleoside analogs(NAs) in HBeAg-positive Chronic Hepatitis B Patients(CHB) patients with subopti
会议
Background:To characterize roles of serum hepatitis B virus markers(HBVM) quantitations in the prediction of natural phases of HBV infection.Methods:149 patients of chronic hepatitis B(CHB) undergone
会议
Background:Hepatitis B surface antigen clearance induced by interferon-α is associated with favorable clinical outcome.In this study,we investigated HBsAg kinetics during pegIFNα treatment and durabil
会议
Background:To discuss the dynamic changes of serum hepatitis B surface antigen(HBsAg) levels,and the serum HBsAg levels apportioned by the same hepatic parenchyma cell volume(HPCV),namely hepatic cell
会议
Background:To evaluate the chronic hepatitis b(CHB) patients by nucleoside(acid),drugs(NAs) after discontinuation of treatment serum levels of IL-21 and its relationship with HBsAg and HBV DNA,working
会议